Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 September 2008, Vol. 112, No. 5, pp. 2055-2061.
Prepublished online as a Blood First Edition Paper on June 17, 2008; DOI 10.1182/blood-2008-04-150276.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Methods and Figures
Right arrow All Versions of this Article:
blood-2008-04-150276v1
112/5/2055    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lasry, I.
Right arrow Articles by Assaraf, Y. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lasry, I.
Right arrow Articles by Assaraf, Y. G.
Related Collections
Right arrow Red Cells
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

RED CELLS

A novel loss-of-function mutation in the proton-coupled folate transporter from a patient with hereditary folate malabsorption reveals that Arg 113 is crucial for function

Inbal Lasry1, Bluma Berman1, Rachel Straussberg2, Yael Sofer3, Hanna Bessler4, Mohamad Sharkia5, Fabian Glaser6, Gerrit Jansen7, Stavit Drori1, and Yehuda G. Assaraf1

1 The Fred Wyszkowski Cancer Research Laboratory, Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel; 2 Department of Child Neurology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; 3 Department of Medicine, C. Sheba Medical Center, Tel-Hashomer, Israel; 4 Laboratory for Immunology and Hematology Research, Rabin Medical Center, Hasharon Hospital, Petach Tikva, Israel; 5 General Health Services, Pediatric Primary Care, Jatt, Israel; 6 Bioinformatics Knowledge Unit, The Lorry I. Lokey Interdisciplinary, Center for Life Sciences and Engineering, Technion, Haifa, Israel; and 7 Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands

Hereditary folate malabsorption (HFM) patients harbor inactivating mutations including R113S in the proton-coupled folate transporter (PCFT), an intestinal folate transporter with optimal activity at acidic pH. Here we identified and characterized a novel R113C mutation residing in the highly conserved first intracellular loop of PCFT. Stable transfectants overexpressing a Myc-tagged wild-type (WT) and mutant R113C PCFT displayed similar transporter targeting to the plasma membrane. However, whereas WT PCFT transfectants showed a 22-fold increase in [3H]folic acid influx at pH 5.5, R113C or mock transfectants showed no increase. Moreover, WT PCFT transfectants displayed a 50% folic acid growth requirement concentration of 7 nM, whereas mock and R113C transfectants revealed 24- to 27-fold higher values. Consistently, upon fluorescein-methotrexate labeling, WT PCFT transfectants displayed a 50% methotrexate displacement concentration of 50 nM, whereas mock and R113C transfectants exhibited 12- to 14-fold higher values. Based on the crystal structure of the homologous Escherichia coli glycerol-3-phosphate transporter, we propose that the cationic R113 residue of PCFT is embedded in a hydrophobic pocket formed by several transmembrane helices that may be part of a folate translocation pore. These findings establish a novel loss of function mutation in HFM residing in an intracellular loop of PCFT crucial for folate transport.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. S. Unal, R. Zhao, M.-H. Chang, A. Fiser, M. F. Romero, and I. D. Goldman
The Functional Roles of the His247 and His281 Residues in Folate and Proton Translocation Mediated by the Human Proton-coupled Folate Transporter SLC46A1
J. Biol. Chem., June 26, 2009; 284(26): 17846 - 17857.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Zhao, S. H. Min, Y. Wang, E. Campanella, P. S. Low, and I. D. Goldman
A Role for the Proton-coupled Folate Transporter (PCFT-SLC46A1) in Folate Receptor-mediated Endocytosis
J. Biol. Chem., February 13, 2009; 284(7): 4267 - 4274.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020